Ron Squarer, CEO at ARRAY BIOPHARMA INC (ARRY), sold 326,876 shares at $18.25 ($6.0M) on 2019-01-30, disclosed to the SEC on 2019-02-01.
Open-market sale of $6.0M ARRY by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.25 | 100,000 | $1.8M | 30.3% |
| 2 | $18.53 | 113,438 | $2.1M | 34.9% |
| 3 | $18.53 | 113,438 | $2.1M | 34.9% |
| Total | $18.44 avg | 326,876 | $6.0M | 100% |
| Filing → |
| ARRY | SELL | 2018-06-29 | $6.6M | — | Filing → |
| ARRY | SELL | 2017-12-19 | $8.9M | — | Filing → |
| ARRY | SELL | 2015-03-04 | $330K | — | Filing → |